Goldman Sachs’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48B | Sell |
2,957,066
-200,160
| -6% | -$96.1M | 0.13% | 132 |
|
|
2026
Q1 | $1.55B | Buy |
3,157,226
+90,342
| +3% | +$49M | 0.18% | 91 |
|
|
2025
Q4 | $1.78B | Buy |
3,066,884
+471,128
| +18% | +$266M | 0.22% | 74 |
|
|
2025
Q3 | $1.26B | Buy |
2,595,756
+274,267
| +12% | +$128M | 0.15% | 113 |
|
|
2025
Q2 | $941M | Sell |
2,321,489
-94,628
| -4% | -$39.6M | 0.13% | 142 |
|
|
2025
Q1 | $1.2B | Buy |
2,416,117
+212,732
| +10% | +$115M | 0.19% | 90 |
|
|
2024
Q4 | $1.15B | Sell |
2,203,385
-259,518
| -11% | -$143M | 0.18% | 90 |
|
|
2024
Q3 | $1.52B | Buy |
2,462,903
+56,455
| +2% | +$33.4M | 0.25% | 70 |
|
|
2024
Q2 | $1.33B | Buy |
2,406,448
+449,816
| +23% | +$258M | 0.23% | 71 |
|
|
2024
Q1 | $1.14B | Buy |
1,956,632
+12,358
| +0.6% | +$6.93M | 0.2% | 87 |
|
|
2023
Q4 | $1.03B | Sell |
1,944,274
-231,600
| -11% | -$112M | 0.19% | 89 |
|
|
2023
Q3 | $1.1B | Buy |
2,175,874
+94,151
| +5% | +$50.2M | 0.23% | 70 |
|
|
2023
Q2 | $1.09B | Buy |
2,081,723
+162,770
| +8% | +$87.8M | 0.23% | 67 |
|
|
2023
Q1 | $1.11B | Sell |
1,918,953
-15,414
| -0.8% | -$8.69M | 0.25% | 63 |
|
|
2022
Q4 | $1.07B | Sell |
1,934,367
-417,186
| -18% | -$221M | 0.26% | 57 |
|
|
2022
Q3 | $1.19B | Buy |
2,351,553
+403,278
| +21% | +$226M | 0.3% | 45 |
|
|
2022
Q2 | $1.06B | Buy |
1,948,275
+554,663
| +40% | +$305M | 0.26% | 56 |
|
|
2022
Q1 | $823M | Sell |
1,393,612
-69,569
| -5% | -$40M | 0.17% | 90 |
|
|
2021
Q4 | $976M | Buy |
1,463,181
+34,670
| +2% | +$21.6M | 0.19% | 78 |
|
|
2021
Q3 | $816M | Buy |
1,428,511
+25,624
| +2% | +$14.1M | 0.17% | 95 |
|
|
2021
Q2 | $708M | Sell |
1,402,887
-132,177
| -9% | -$62.4M | 0.16% | 109 |
|
|
2021
Q1 | $701M | Buy |
1,535,064
+8,603
| +0.6% | +$4.11M | 0.18% | 92 |
|
|
2020
Q4 | $711M | Buy |
1,526,461
+368,029
| +32% | +$173M | 0.18% | 91 |
|
|
2020
Q3 | $511M | Sell |
1,158,432
-373,678
| -24% | -$154M | 0.15% | 127 |
|
|
2020
Q2 | $555M | Sell |
1,532,110
-228,003
| -13% | -$76.4M | 0.17% | 102 |
|
|
2020
Q1 | $499M | Sell |
1,760,113
-389,749
| -18% | -$123M | 0.18% | 105 |
|
|
2019
Q4 | $698M | Buy |
2,149,862
+41,748
| +2% | +$12.7M | 0.18% | 103 |
|
|
2019
Q3 | $614M | Sell |
2,108,114
-51,096
| -2% | -$14.6M | 0.18% | 95 |
|
|
2019
Q2 | $634M | Buy |
2,159,210
+510,572
| +31% | +$141M | 0.18% | 94 |
|
|
2019
Q1 | $451M | Sell |
1,648,638
-403,085
| -20% | -$100M | 0.14% | 129 |
|
|
2018
Q4 | $459M | Buy |
2,051,723
+233,041
| +13% | +$54.7M | 0.15% | 110 |
|
|
2018
Q3 | $444M | Sell |
1,818,682
-57,029
| -3% | -$13.1M | 0.11% | 165 |
|
|
2018
Q2 | $389M | Sell |
1,875,711
-497,458
| -21% | -$106M | 0.11% | 179 |
|
|
2018
Q1 | $490M | Buy |
2,373,169
+361,630
| +18% | +$75.9M | 0.13% | 166 |
|
|
2017
Q4 | $382M | Sell |
2,011,539
-10,609
| -0.5% | -$2.03M | 0.09% | 222 |
|
|
2017
Q3 | $383M | Sell |
2,022,148
-69,607
| -3% | -$12.6M | 0.09% | 197 |
|
|
2017
Q2 | $365M | Buy |
2,091,755
+339,897
| +19% | +$57.1M | 0.09% | 195 |
|
|
2017
Q1 | $269M | Buy |
1,751,858
+184,965
| +12% | +$28.3M | 0.07% | 278 |
|
|
2016
Q4 | $221M | Buy |
1,566,893
+75,367
| +5% | +$11.1M | 0.06% | 357 |
|
|
2016
Q3 | $237M | Buy |
1,491,526
+178,656
| +14% | +$27.5M | 0.07% | 282 |
|
|
2016
Q2 | $194M | Sell |
1,312,870
-151,851
| -10% | -$22.4M | 0.06% | 356 |
|
|
2016
Q1 | $207M | Buy |
1,464,721
+93,234
| +7% | +$12.5M | 0.07% | 329 |
|
|
2015
Q4 | $195M | Buy |
1,371,487
+538,075
| +65% | +$71.8M | 0.06% | 364 |
|
|
2015
Q3 | $102M | Buy |
833,412
+169,825
| +26% | +$22.1M | 0.03% | 610 |
|
|
2015
Q2 | $86.1M | Sell |
663,587
-393,499
| -37% | -$51.3M | 0.03% | 759 |
|
|
2015
Q1 | $142M | Buy |
1,057,086
+89,460
| +9% | +$11.5M | 0.05% | 492 |
|
|
2014
Q4 | $121M | Buy |
967,626
+295,996
| +44% | +$36M | 0.04% | 580 |
|
|
2014
Q3 | $81.7M | Sell |
671,630
-373,768
| -36% | -$45.4M | 0.03% | 746 |
|
|
2014
Q2 | $123M | Buy |
1,045,398
+80,840
| +8% | +$9.51M | 0.04% | 564 |
|
|
2014
Q1 | $116M | Sell |
964,558
-142,714
| -13% | -$17M | 0.04% | 558 |
|
|
2013
Q4 | $123M | Buy |
1,107,272
+249,563
| +29% | +$24.8M | 0.04% | 539 |
|
|
2013
Q3 | $79M | Buy |
857,709
+29,699
| +4% | +$2.69M | 0.03% | 694 |
|
|
2013
Q2 | $70.1M | Buy |
+828,010
| New | +$68.9M | 0.03% | 710 |
|
Other funds holding TMO
Goldman Sachs's TMO Position: Q2 2026 in Review
Goldman Sachs reduced its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, selling an estimated $96.1M and leaving 2,957,066 shares worth $1.48B. The position accounts for 0.13% of the portfolio, ranked #132.
Goldman Sachs first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.78B in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Goldman Sachs held 2,957,066 shares of Thermo Fisher Scientific worth $1.48B as of Q2 2026.
- Goldman Sachs sold 200,160 Thermo Fisher Scientific shares in Q2 2026, an estimated $96.1M.
- Thermo Fisher Scientific made up 0.13% of Goldman Sachs's portfolio in Q2 2026, its #132 holding.
- Goldman Sachs first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Thermo Fisher Scientific position peaked at $1.78B in Q4 2025.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.